Soo Young Hwang

8PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityContaminant hydrologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 27, 2026
GLP-1 receptor agonists and Risk of Cardiovascular and Pulmonary Complications in patients with OSA and Type 2 Diabetes Mellitus.

|Feb 12, 2026
Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis.

Mohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari

|May 16, 2025
Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Soo Young Hwang, Mohammad Saeid Rezaee-Zavareh, Abdelrahman M Attia

|Apr 30, 2025
Asymptomatic Massive Choledocholithiasis in a Patient With Sickle Cell Disease and History of Remote Cholecystectomy.

Soo Young Hwang, Maria Mironova, Mary Lacy Grecco

|Oct 25, 2024
Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.

Abdelrahman M Attia, Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang

|Sep 19, 2024
Steroid-refractory immune checkpoint inhibitor (ICI) hepatitis and ICI rechallenge: A systematic review and meta-analysis.

Soo Young Hwang, Pinghsin Hsieh, Wei Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Abdelrahman M Attia

2 joint publications

Amit G Singal

2 joint publications

Jae Il Shin

2 joint publications

Ju Dong Yang